[免疫治疗的肺部并发症,它们的识别和治疗]
1Szent-Györgyi Albert Klinikai Központ, Szegedi Tudományegyetem, Tüdőgyógyászati Klinika, Szeged, Hungary. palfoldi.regina@szte.hu.
Magyar onkologia
|December 12, 2025
概括
免疫检查点抑制剂在癌症治疗中提供了突破性进展,但可能导致与免疫相关的肺炎. 早期识别和管理对于患者的安全和治疗的延续至关重要.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 在治疗各种固体瘤方面取得了重大进展.
- 肺部并发症,特别是与免疫相关的肺炎,是ICI治疗的关键副作用.
研究的目的:
- 提供与ICI相关的肺免疫相关不良事件 (irAEs) 的全面概述.
- 详细介绍这些肺部并发症的临床和放射性特征.
- 审查目前对肺部IRAE的管理策略.
主要方法:
- 对ICI相关的肺毒性临床研究和病例报告的文献综述.
- 对免疫相关肺炎的诊断标准和成像检测结果的分析.
- 综合治疗指南和建议,以管理肺部IRAEs.
主要成果:
- 免疫相关的肺炎是一种频繁和严重的不良事件,通常带有非特异性症状.
- 由于感染和其他呼吸道疾病的症状重叠,差异诊断可能具有挑战性.
- 放射学发现有所不同,但对于诊断至关重要.
结论:
- 迅速识别和诊断肺部IREs对于有效管理至关重要.
- 适当的治疗对于确保治疗连续性和患者安全至关重要.
- 本综述提供了关于识别和管理这些可能危及生命的肺部并发症的指导.
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Other Pulmonary Disorders
1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K
Pneumonia III: Complications and Assessment
756
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
756
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K


